These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 6359986)
1. Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection. Rodriguez-Carlos A; Raúl A; Jacobo-Delgado YM; Serrano CJ; Santos-Mena A; De Jesus-Gonzalez LA; Boix E; Rivas-Santiago B Can J Microbiol; 2024 Jul; 70(7):252-261. PubMed ID: 38855942 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterium avium-intracellulare contamination of mammalian cell cultures. Lelong-Rebel IH; Piemont Y; Fabre M; Rebel G In Vitro Cell Dev Biol Anim; 2009; 45(1-2):75-90. PubMed ID: 18855078 [TBL] [Abstract][Full Text] [Related]
3. Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation. Alvarez M; Saylor C; Casadevall A Cell Microbiol; 2008 Aug; 10(8):1622-33. PubMed ID: 18384661 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Hayashi T; Rao SP; Takabayashi K; Van Uden JH; Kornbluth RS; Baird SM; Taylor MW; Carson DA; Catanzaro A; Raz E Infect Immun; 2001 Oct; 69(10):6156-64. PubMed ID: 11553555 [TBL] [Abstract][Full Text] [Related]
5. Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation. Gomez-Flores R; Hsia R; Tamez-Guerra R; Mehta RT Antimicrob Agents Chemother; 1996 Nov; 40(11):2545-9. PubMed ID: 8913461 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Saunders BM; Cheers C Infect Immun; 1995 Jun; 63(6):2282-7. PubMed ID: 7768610 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. Crowle AJ; Tsang AY; Vatter AE; May MH J Clin Microbiol; 1986 Nov; 24(5):812-21. PubMed ID: 3771767 [TBL] [Abstract][Full Text] [Related]
8. Superoxide dismutase activity of Mycobacterium avium, M. intracellulare, and M. scrofulaceum. Mayer BK; Falkinham JO Infect Immun; 1986 Sep; 53(3):631-5. PubMed ID: 3744555 [TBL] [Abstract][Full Text] [Related]
9. Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditions. Gangadharam PR; Kesavalu L; Rao PN; Perumal VK; Iseman MD Antimicrob Agents Chemother; 1988 Jun; 32(6):886-9. PubMed ID: 3415209 [TBL] [Abstract][Full Text] [Related]
11. Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection. Stokes RW; Collins FM Infect Immun; 1988 Sep; 56(9):2250-4. PubMed ID: 3137164 [TBL] [Abstract][Full Text] [Related]
12. Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Frehel C; de Chastellier C; Lang T; Rastogi N Infect Immun; 1986 Apr; 52(1):252-62. PubMed ID: 2870027 [TBL] [Abstract][Full Text] [Related]
13. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Gangadharam PR; Perumal VK; Podapati NR; Kesavalu L; Iseman MD Antimicrob Agents Chemother; 1988 Sep; 32(9):1400-3. PubMed ID: 2848444 [TBL] [Abstract][Full Text] [Related]